{
    "users": [
      { "id": 1, "name": "Alice", "email": "alice@example.com" },
      { "id": 2, "name": "Bob", "email": "bob@example.com" }
    ],
    "products": [
      { "id": 1, "name": "Laptop", "price": 1299.99 },
      { "id": 2, "name": "Phone", "price": 699.99 }
    ],
    "orders": [
      { "id": 1, "userId": 1, "productId": 2, "quantity": 1 },
      { "id": 2, "userId": 2, "productId": 1, "quantity": 2 }
    ],
    "logout": {},
    "sellers": [],
    "buyers": [
      {
        "id": 1,
        "profile_theme": "green",
        "user_name": "user001",
        "promotion_text": "Embracing the Entire ASEAN Region: The Most Extensive Medical Distribution Network",
        "company_name": "EP Plus Group",
        "company_logo": "/example_logo.png",
        "company_logo_small": "/example_logo_small.png",
        "company_description": "EP Plus is a regional healthcare corporation based in Malaysia, with a robust foothold in Malaysia, Singapore, Indonesia, Philippines and expanding across Southeast Asia.\n\n\nSince our inception in 1997, we are driven by our mission to make innovative European medical possibilities – pharmaceuticals, medical devices and equipment accessible to patients throughout Southeast Asia.",
        "company_location": "Taiwan",
        "company_established_year": "2001",
        "company_overview": "/company-overview.jpg",
        "business_annual_revenue": "5000000.00",
        "business_capital_amount": "1000000.00",
        "number_of_employees": 120,
        "company_website": "https://alphamaterials.com",
        "business_attributes": ["Distributor / Agent"],
        "business_nature": ["Pharmaceutical Distribution"],
        "industry_classification": "先進材料",
        "partnership_looking_for": ["OEM/ODM", "Product Distribution Franchise"],
        "purchasing_requirement": ["Gastroenterology", "Neurology / CNS", "Respiratory", "Gynecology", "Endocrinology / Diabetes", "Reproductive Health", "Aesthetic / Dermatology"],
        "required_certification": "ISO 9001",
        "market_channel_overview": "全球OEM廠商",
        "company_strengths": "研發創新速度快",
        "estimated_procurement_amount": "200000.00",
        "brands_in_distribution": "AlphaFiber",
        "time_zone": "UTC+08:00 (Asia/Taipei)",
        "languages": ["English", "Chinese"]
      },
      {
        "id": 2,
        "profile_theme": "blue",
        "user_name": "user002",
        "promotion_text": "Embracing the Entire ASEAN Region: The Most Extensive Medical Distribution Network",
        "company_name": "EP Plus Group",
        "company_logo": "/example_logo.png",
        "company_logo_small": "/example_logo_small.png",
        "company_description": "EP Plus is a regional healthcare corporation based in Malaysia, with a robust foothold in Malaysia, Singapore, Indonesia, Philippines and expanding across Southeast Asia.\n\n\nSince our inception in 1997, we are driven by our mission to make innovative European medical possibilities – pharmaceuticals, medical devices and equipment accessible to patients throughout Southeast Asia.",
        "company_location": "Taiwan",
        "company_established_year": "2001",
        "company_overview": "/company-overview.jpg",
        "business_annual_revenue": "5000000.00",
        "business_capital_amount": "1000000.00",
        "number_of_employees": 120,
        "company_website": "https://alphamaterials.com",
        "business_attributes": ["Distributor / Agent"],
        "business_nature": ["Pharmaceutical Distribution"],
        "industry_classification": "先進材料",
        "partnership_looking_for": ["OEM/ODM", "Product Distribution Franchise"],
        "purchasing_requirement": ["Gastroenterology", "Neurology / CNS", "Respiratory", "Gynecology", "Endocrinology / Diabetes", "Reproductive Health", "Aesthetic / Dermatology"],
        "required_certification": "ISO 9001",
        "market_channel_overview": "全球OEM廠商",
        "company_strengths": "研發創新速度快",
        "estimated_procurement_amount": "200000.00",
        "brands_in_distribution": "AlphaFiber",
        "time_zone": "UTC+08:00 (Asia/Taipei)",
        "languages": ["English", "Chinese"]
      },
      {
        "id": 3,
        "profile_theme": "red",
        "user_name": "user003",
        "promotion_text": "Embracing the Entire ASEAN Region: The Most Extensive Medical Distribution Network",
        "company_name": "EP Plus Group",
        "company_logo": "/example_logo.png",
        "company_logo_small": "/example_logo_small.png",
        "company_description": "EP Plus is a regional healthcare corporation based in Malaysia, with a robust foothold in Malaysia, Singapore, Indonesia, Philippines and expanding across Southeast Asia.\n\n\nSince our inception in 1997, we are driven by our mission to make innovative European medical possibilities – pharmaceuticals, medical devices and equipment accessible to patients throughout Southeast Asia.",
        "company_location": "Taiwan",
        "company_established_year": "2001",
        "company_overview": "/company-overview.jpg",
        "business_annual_revenue": "5000000.00",
        "business_capital_amount": "1000000.00",
        "number_of_employees": 120,
        "company_website": "https://alphamaterials.com",
        "business_attributes": ["Distributor / Agent"],
        "business_nature": ["Pharmaceutical Distribution"],
        "industry_classification": "先進材料",
        "partnership_looking_for": ["OEM/ODM", "Product Distribution Franchise"],
        "purchasing_requirement": ["Gastroenterology", "Neurology / CNS", "Respiratory", "Gynecology", "Endocrinology / Diabetes", "Reproductive Health", "Aesthetic / Dermatology"],
        "required_certification": "ISO 9001",
        "market_channel_overview": "全球OEM廠商",
        "company_strengths": "研發創新速度快",
        "estimated_procurement_amount": "200000.00",
        "brands_in_distribution": "AlphaFiber",
        "time_zone": "UTC+08:00 (Asia/Taipei)",
        "languages": ["English", "Chinese"]
      },
      {
        "id": 4,
        "profile_theme": "green",
        "user_name": "user001",
        "promotion_text": "Embracing the Entire ASEAN Region: The Most Extensive Medical Distribution Network",
        "company_name": "EP Plus Group",
        "company_logo": "/example_logo.png",
        "company_logo_small": "/example_logo_small.png",
        "company_description": "EP Plus is a regional healthcare corporation based in Malaysia, with a robust foothold in Malaysia, Singapore, Indonesia, Philippines and expanding across Southeast Asia.\n\n\nSince our inception in 1997, we are driven by our mission to make innovative European medical possibilities – pharmaceuticals, medical devices and equipment accessible to patients throughout Southeast Asia.",
        "company_location": "Taiwan",
        "company_established_year": "2001",
        "company_overview": "/company-overview.jpg",
        "business_annual_revenue": "5000000.00",
        "business_capital_amount": "1000000.00",
        "number_of_employees": 120,
        "company_website": "https://alphamaterials.com",
        "business_attributes": ["Distributor / Agent"],
        "business_nature": ["Pharmaceutical Distribution"],
        "industry_classification": "先進材料",
        "partnership_looking_for": ["OEM/ODM", "Product Distribution Franchise"],
        "purchasing_requirement": ["Gastroenterology", "Neurology / CNS", "Respiratory", "Gynecology", "Endocrinology / Diabetes", "Reproductive Health", "Aesthetic / Dermatology"],
        "required_certification": "ISO 9001",
        "market_channel_overview": "全球OEM廠商",
        "company_strengths": "研發創新速度快",
        "estimated_procurement_amount": "200000.00",
        "brands_in_distribution": "AlphaFiber",
        "time_zone": "UTC+08:00 (Asia/Taipei)",
        "languages": ["English", "Chinese"]
      },
      {
        "id": 5,
        "profile_theme": "blue",
        "user_name": "user002",
        "promotion_text": "Embracing the Entire ASEAN Region: The Most Extensive Medical Distribution Network",
        "company_name": "EP Plus Group",
        "company_logo": "/example_logo.png",
        "company_logo_small": "/example_logo_small.png",
        "company_description": "EP Plus is a regional healthcare corporation based in Malaysia, with a robust foothold in Malaysia, Singapore, Indonesia, Philippines and expanding across Southeast Asia.\n\n\nSince our inception in 1997, we are driven by our mission to make innovative European medical possibilities – pharmaceuticals, medical devices and equipment accessible to patients throughout Southeast Asia.",
        "company_location": "Taiwan",
        "company_established_year": "2001",
        "company_overview": "/company-overview.jpg",
        "business_annual_revenue": "5000000.00",
        "business_capital_amount": "1000000.00",
        "number_of_employees": 120,
        "company_website": "https://alphamaterials.com",
        "business_attributes": ["Distributor / Agent"],
        "business_nature": ["Pharmaceutical Distribution"],
        "industry_classification": "先進材料",
        "partnership_looking_for": ["OEM/ODM", "Product Distribution Franchise"],
        "purchasing_requirement": ["Gastroenterology", "Neurology / CNS", "Respiratory", "Gynecology", "Endocrinology / Diabetes", "Reproductive Health", "Aesthetic / Dermatology"],
        "required_certification": "ISO 9001",
        "market_channel_overview": "全球OEM廠商",
        "company_strengths": "研發創新速度快",
        "estimated_procurement_amount": "200000.00",
        "brands_in_distribution": "AlphaFiber",
        "time_zone": "UTC+08:00 (Asia/Taipei)",
        "languages": ["English", "Chinese"]
      },
      {
        "id": 6,
        "profile_theme": "red",
        "user_name": "user003",
        "promotion_text": "Embracing the Entire ASEAN Region: The Most Extensive Medical Distribution Network",
        "company_name": "EP Plus Group",
        "company_logo": "/example_logo.png",
        "company_logo_small": "/example_logo_small.png",
        "company_description": "EP Plus is a regional healthcare corporation based in Malaysia, with a robust foothold in Malaysia, Singapore, Indonesia, Philippines and expanding across Southeast Asia.\n\n\nSince our inception in 1997, we are driven by our mission to make innovative European medical possibilities – pharmaceuticals, medical devices and equipment accessible to patients throughout Southeast Asia.",
        "company_location": "Taiwan",
        "company_established_year": "2001",
        "company_overview": "/company-overview.jpg",
        "business_annual_revenue": "5000000.00",
        "business_capital_amount": "1000000.00",
        "number_of_employees": 120,
        "company_website": "https://alphamaterials.com",
        "business_attributes": ["Distributor / Agent"],
        "business_nature": ["Pharmaceutical Distribution"],
        "industry_classification": "先進材料",
        "partnership_looking_for": ["OEM/ODM", "Product Distribution Franchise"],
        "purchasing_requirement": ["Gastroenterology", "Neurology / CNS", "Respiratory", "Gynecology", "Endocrinology / Diabetes", "Reproductive Health", "Aesthetic / Dermatology"],
        "required_certification": "ISO 9001",
        "market_channel_overview": "全球OEM廠商",
        "company_strengths": "研發創新速度快",
        "estimated_procurement_amount": "200000.00",
        "brands_in_distribution": "AlphaFiber",
        "time_zone": "UTC+08:00 (Asia/Taipei)",
        "languages": ["English", "Chinese"]
      },
      {
        "id": 7,
        "profile_theme": "green",
        "user_name": "user001",
        "promotion_text": "Embracing the Entire ASEAN Region: The Most Extensive Medical Distribution Network",
        "company_name": "EP Plus Group",
        "company_logo": "/example_logo.png",
        "company_logo_small": "/example_logo_small.png",
        "company_description": "EP Plus is a regional healthcare corporation based in Malaysia, with a robust foothold in Malaysia, Singapore, Indonesia, Philippines and expanding across Southeast Asia.\n\n\nSince our inception in 1997, we are driven by our mission to make innovative European medical possibilities – pharmaceuticals, medical devices and equipment accessible to patients throughout Southeast Asia.",
        "company_location": "Taiwan",
        "company_established_year": "2001",
        "company_overview": "/company-overview.jpg",
        "business_annual_revenue": "5000000.00",
        "business_capital_amount": "1000000.00",
        "number_of_employees": 120,
        "company_website": "https://alphamaterials.com",
        "business_attributes": ["Distributor / Agent"],
        "business_nature": ["Pharmaceutical Distribution"],
        "industry_classification": "先進材料",
        "partnership_looking_for": ["OEM/ODM", "Product Distribution Franchise"],
        "purchasing_requirement": ["Gastroenterology", "Neurology / CNS", "Respiratory", "Gynecology", "Endocrinology / Diabetes", "Reproductive Health", "Aesthetic / Dermatology"],
        "required_certification": "ISO 9001",
        "market_channel_overview": "全球OEM廠商",
        "company_strengths": "研發創新速度快",
        "estimated_procurement_amount": "200000.00",
        "brands_in_distribution": "AlphaFiber",
        "time_zone": "UTC+08:00 (Asia/Taipei)",
        "languages": ["English", "Chinese"]
      },
      {
        "id": 8,
        "profile_theme": "blue",
        "user_name": "user002",
        "promotion_text": "Embracing the Entire ASEAN Region: The Most Extensive Medical Distribution Network",
        "company_name": "EP Plus Group",
        "company_logo": "/example_logo.png",
        "company_logo_small": "/example_logo_small.png",
        "company_description": "EP Plus is a regional healthcare corporation based in Malaysia, with a robust foothold in Malaysia, Singapore, Indonesia, Philippines and expanding across Southeast Asia.\n\n\nSince our inception in 1997, we are driven by our mission to make innovative European medical possibilities – pharmaceuticals, medical devices and equipment accessible to patients throughout Southeast Asia.",
        "company_location": "Taiwan",
        "company_established_year": "2001",
        "company_overview": "/company-overview.jpg",
        "business_annual_revenue": "5000000.00",
        "business_capital_amount": "1000000.00",
        "number_of_employees": 120,
        "company_website": "https://alphamaterials.com",
        "business_attributes": ["Distributor / Agent"],
        "business_nature": ["Pharmaceutical Distribution"],
        "industry_classification": "先進材料",
        "partnership_looking_for": ["OEM/ODM", "Product Distribution Franchise"],
        "purchasing_requirement": ["Gastroenterology", "Neurology / CNS", "Respiratory", "Gynecology", "Endocrinology / Diabetes", "Reproductive Health", "Aesthetic / Dermatology"],
        "required_certification": "ISO 9001",
        "market_channel_overview": "全球OEM廠商",
        "company_strengths": "研發創新速度快",
        "estimated_procurement_amount": "200000.00",
        "brands_in_distribution": "AlphaFiber",
        "time_zone": "UTC+08:00 (Asia/Taipei)",
        "languages": ["English", "Chinese"]
      },
      {
        "id": 9,
        "profile_theme": "red",
        "user_name": "user003",
        "promotion_text": "Embracing the Entire ASEAN Region: The Most Extensive Medical Distribution Network",
        "company_name": "EP Plus Group",
        "company_logo": "/example_logo.png",
        "company_logo_small": "/example_logo_small.png",
        "company_description": "EP Plus is a regional healthcare corporation based in Malaysia, with a robust foothold in Malaysia, Singapore, Indonesia, Philippines and expanding across Southeast Asia.\n\n\nSince our inception in 1997, we are driven by our mission to make innovative European medical possibilities – pharmaceuticals, medical devices and equipment accessible to patients throughout Southeast Asia.",
        "company_location": "Taiwan",
        "company_established_year": "2001",
        "company_overview": "/company-overview.jpg",
        "business_annual_revenue": "5000000.00",
        "business_capital_amount": "1000000.00",
        "number_of_employees": 120,
        "company_website": "https://alphamaterials.com",
        "business_attributes": ["Distributor / Agent"],
        "business_nature": ["Pharmaceutical Distribution"],
        "industry_classification": "先進材料",
        "partnership_looking_for": ["OEM/ODM", "Product Distribution Franchise"],
        "purchasing_requirement": ["Gastroenterology", "Neurology / CNS", "Respiratory", "Gynecology", "Endocrinology / Diabetes", "Reproductive Health", "Aesthetic / Dermatology"],
        "required_certification": "ISO 9001",
        "market_channel_overview": "全球OEM廠商",
        "company_strengths": "研發創新速度快",
        "estimated_procurement_amount": "200000.00",
        "brands_in_distribution": "AlphaFiber",
        "time_zone": "UTC+08:00 (Asia/Taipei)",
        "languages": ["English", "Chinese"]
      },
      {
        "id": 10,
        "profile_theme": "green",
        "user_name": "user001",
        "promotion_text": "Embracing the Entire ASEAN Region: The Most Extensive Medical Distribution Network",
        "company_name": "EP Plus Group",
        "company_logo": "/example_logo.png",
        "company_logo_small": "/example_logo_small.png",
        "company_description": "EP Plus is a regional healthcare corporation based in Malaysia, with a robust foothold in Malaysia, Singapore, Indonesia, Philippines and expanding across Southeast Asia.\n\n\nSince our inception in 1997, we are driven by our mission to make innovative European medical possibilities – pharmaceuticals, medical devices and equipment accessible to patients throughout Southeast Asia.",
        "company_location": "Taiwan",
        "company_established_year": "2001",
        "company_overview": "/company-overview.jpg",
        "business_annual_revenue": "5000000.00",
        "business_capital_amount": "1000000.00",
        "number_of_employees": 120,
        "company_website": "https://alphamaterials.com",
        "business_attributes": ["Distributor / Agent"],
        "business_nature": ["Pharmaceutical Distribution"],
        "industry_classification": "先進材料",
        "partnership_looking_for": ["OEM/ODM", "Product Distribution Franchise"],
        "purchasing_requirement": ["Gastroenterology", "Neurology / CNS", "Respiratory", "Gynecology", "Endocrinology / Diabetes", "Reproductive Health", "Aesthetic / Dermatology"],
        "required_certification": "ISO 9001",
        "market_channel_overview": "全球OEM廠商",
        "company_strengths": "研發創新速度快",
        "estimated_procurement_amount": "200000.00",
        "brands_in_distribution": "AlphaFiber",
        "time_zone": "UTC+08:00 (Asia/Taipei)",
        "languages": ["English", "Chinese"]
      },
      {
        "id": 11,
        "profile_theme": "blue",
        "user_name": "user002",
        "promotion_text": "Embracing the Entire ASEAN Region: The Most Extensive Medical Distribution Network",
        "company_name": "EP Plus Group",
        "company_logo": "/example_logo.png",
        "company_logo_small": "/example_logo_small.png",
        "company_description": "EP Plus is a regional healthcare corporation based in Malaysia, with a robust foothold in Malaysia, Singapore, Indonesia, Philippines and expanding across Southeast Asia.\n\n\nSince our inception in 1997, we are driven by our mission to make innovative European medical possibilities – pharmaceuticals, medical devices and equipment accessible to patients throughout Southeast Asia.",
        "company_location": "Taiwan",
        "company_established_year": "2001",
        "company_overview": "/company-overview.jpg",
        "business_annual_revenue": "5000000.00",
        "business_capital_amount": "1000000.00",
        "number_of_employees": 120,
        "company_website": "https://alphamaterials.com",
        "business_attributes": ["Distributor / Agent"],
        "business_nature": ["Pharmaceutical Distribution"],
        "industry_classification": "先進材料",
        "partnership_looking_for": ["OEM/ODM", "Product Distribution Franchise"],
        "purchasing_requirement": ["Gastroenterology", "Neurology / CNS", "Respiratory", "Gynecology", "Endocrinology / Diabetes", "Reproductive Health", "Aesthetic / Dermatology"],
        "required_certification": "ISO 9001",
        "market_channel_overview": "全球OEM廠商",
        "company_strengths": "研發創新速度快",
        "estimated_procurement_amount": "200000.00",
        "brands_in_distribution": "AlphaFiber",
        "time_zone": "UTC+08:00 (Asia/Taipei)",
        "languages": ["English", "Chinese"]
      },
      {
        "id": 12,
        "profile_theme": "red",
        "user_name": "user003",
        "promotion_text": "Embracing the Entire ASEAN Region: The Most Extensive Medical Distribution Network",
        "company_name": "EP Plus Group",
        "company_logo": "/example_logo.png",
        "company_logo_small": "/example_logo_small.png",
        "company_description": "EP Plus is a regional healthcare corporation based in Malaysia, with a robust foothold in Malaysia, Singapore, Indonesia, Philippines and expanding across Southeast Asia.\n\n\nSince our inception in 1997, we are driven by our mission to make innovative European medical possibilities – pharmaceuticals, medical devices and equipment accessible to patients throughout Southeast Asia.",
        "company_location": "Taiwan",
        "company_established_year": "2001",
        "company_overview": "/company-overview.jpg",
        "business_annual_revenue": "5000000.00",
        "business_capital_amount": "1000000.00",
        "number_of_employees": 120,
        "company_website": "https://alphamaterials.com",
        "business_attributes": ["Distributor / Agent"],
        "business_nature": ["Pharmaceutical Distribution"],
        "industry_classification": "先進材料",
        "partnership_looking_for": ["OEM/ODM", "Product Distribution Franchise"],
        "purchasing_requirement": ["Gastroenterology", "Neurology / CNS", "Respiratory", "Gynecology", "Endocrinology / Diabetes", "Reproductive Health", "Aesthetic / Dermatology"],
        "required_certification": "ISO 9001",
        "market_channel_overview": "全球OEM廠商",
        "company_strengths": "研發創新速度快",
        "estimated_procurement_amount": "200000.00",
        "brands_in_distribution": "AlphaFiber",
        "time_zone": "UTC+08:00 (Asia/Taipei)",
        "languages": ["English", "Chinese"]
      }
    ],
    "buyers_contact": [
      {
        "id": 1,
        "buyer_name": "Eric Khor",
        "buyer_job_title": "Vice President",
        "brief_introduction": "超過10年材料領域經驗",
        "buyer_contact_location": "Malaysia, Singapore, Indonesia, Philippines",
        "buyer_photo": "/buyer_photo.png"
      },
      {
        "id": 2,
        "buyer_name": "Eric Khor",
        "buyer_job_title": "Vice President",
        "brief_introduction": "超過10年材料領域經驗",
        "buyer_contact_location": "Malaysia, Singapore, Indonesia, Philippines",
        "buyer_photo": "/buyer_photo.png"
      },
      {
        "id": 3,
        "buyer_name": "Eric Khor",
        "buyer_job_title": "Vice President",
        "brief_introduction": "超過10年材料領域經驗",
        "buyer_contact_location": "Malaysia, Singapore, Indonesia, Philippines",
        "buyer_photo": "/buyer_photo.png"
      }
    ],
    "filter_options": {
      "purchasing_requirement": {
        "703": "Smart Hospital & IT Solutions",
        "705": "Diagnostics & Laboratory",
        "706": "Digital Health",
        "707": "Biopharmaceuticals",
        "721": "Medical Devices",
        "722": "Health & Wellness",
        "725": "Long Term Care & Rehab"
      },
      "partnership_looking_for": {
        "710": "CDMO / CMO",
        "711": "OEM / ODM",
        "712": "Co-Development",
        "713": "Technology Licensing"
      },
      "region_covered": {
        "732": "Singapore",
        "733": "Indonesia"
      }
    },
    "recommended": [
      {
        "id": 0,
        "position": "top",
        "theme": "a",
        "image": "/product1.png",
        "name": "Microbiology Consumables"
      },
      {
        "id": 1,
        "position": "top",
        "theme": "b",
        "image": "/product2.png",
        "name": "Diagnostic Imaging Equipment"
      },
      {
        "id": 2,
        "position": "bottom",
        "theme": "a",
        "image": "/product3.png",
        "name": "Da Vinci Surgical Instruments"
      },
      {
        "id": 3,
        "position": "center",
        "theme": "c",
        "name": "2025\nIBMI Caner Medicines\nOnline Live Conference",
        "date": "Aug 19, 19:00-21:00"
      }
    ],
    "conference": {
      "title": "2024 MEDTEX Summit Asia",
      "subtitle": "Leading innovation, investing in the future",
      "date": "2024.12.03(Tue)",
      "location": "3F, Ballroom, Le Méridien Taipei",
      "organizers": ["Everbright Biofund", "RBMP"],
      "supporters": ["National Science and Technology Council (NSTC)", "National Development Council (NDC)"],
      "themes": ["Advanced AI applications", "Regenerative medicine", "Immunotherapies", "Breakthrough drug development", "Innovative medical devices"],
      "logo": "https://expo.taiwan-healthcare.org//data/tmp/20230928/20230928epf7fo.svg",
      "expo_logo": "https://expo.taiwan-healthcare.org//data/tmp/20241104/202411047ytqkg.png",
      "background_image": "https://expo.taiwan-healthcare.org//data/tmp/20230928/202309282l9cde.gif"
    },
    "speakers": [
      {
        "id": 1,
        "name": "Ettikan Karuppiah",
        "title": "Director & Technologist, NVIDIA",
        "photo": "https://expo.taiwan-healthcare.org//data/tmp/20241125/20241125pgynrb.jpg"
      },
      {
        "id": 2,
        "name": "Keren Priyadarshini",
        "title": "Healthcare Lead, Microsoft Asia",
        "photo": "https://expo.taiwan-healthcare.org//data/tmp/20241106/20241106rc6gfu.jpg"
      },
      {
        "id": 3,
        "name": "Charles Lin",
        "title": "Principal, illumina Ventures",
        "photo": "https://expo.taiwan-healthcare.org//data/tmp/20241028/20241028xc4re6.jpg"
      },
      {
        "id": 4,
        "name": "Robert Mittendorff",
        "title": "General Partner & Head of Healthcare, B Capital",
        "photo": "https://expo.taiwan-healthcare.org//data/tmp/20241122/202411228uf8an.jpeg"
      },
      {
        "id": 5,
        "name": "Ian Chiang",
        "title": "Partner, Flare Capital Partners",
        "photo": "https://expo.taiwan-healthcare.org//data/tmp/20241106/20241106lbsh6z.jpg"
      },
      {
        "id": 6,
        "name": "Nate Chang",
        "title": "Operating Partner, Playground Global",
        "photo": "https://expo.taiwan-healthcare.org//data/tmp/20241118/202411180cv8jj.webp"
      },
      {
        "id": 7,
        "name": "Cheryl Cheng",
        "title": "Founder, Vive Collective",
        "photo": "https://expo.taiwan-healthcare.org//data/tmp/20241108/202411082dgc5h.jpg"
      },
      {
        "id": 8,
        "name": "Zubin Daruwalla",
        "title": "Asia Pacific Health Industries Leader, PwC Singapore",
        "photo": "https://expo.taiwan-healthcare.org//data/tmp/20241107/20241107k8bmq6.jpg"
      }
    ],
    "startups": [
      {
        "id": 1,
        "name": "Tempo Therapeutics",
        "description": "微孔凝膠組織再生全新材料",
        "presenter": "Westbrook Weaver",
        "presenter_title": "Founder/CEO",
        "photo": "https://expo.taiwan-healthcare.org//data/tmp/20241028/202410285ts46s.jpg",
        "category": "Regenerative Medicine"
      },
      {
        "id": 2,
        "name": "EyeYon",
        "description": "人工眼角膜移植新科技！",
        "presenter": "Nahum Ferera",
        "presenter_title": "CEO/ Co-Founder",
        "photo": "https://expo.taiwan-healthcare.org//data/tmp/20241028/20241028xqekka.jpeg",
        "category": "Regenerative Medicine"
      },
      {
        "id": 3,
        "name": "EpiBone",
        "description": "創新脂肪幹細胞製程生成骨移植物",
        "presenter": "Nina Tandon",
        "presenter_title": "CEO",
        "photo": "https://expo.taiwan-healthcare.org//data/tmp/20241028/20241028y81103.jpeg",
        "category": "Regenerative Medicine"
      },
      {
        "id": 4,
        "name": "Arbor Biotechnologies",
        "description": "張鋒團隊 !全球最新高效CRISPR平台",
        "presenter": "David Cheng",
        "presenter_title": "CTO",
        "photo": "https://expo.taiwan-healthcare.org//data/tmp/20241028/202410280h2pfw.jpg",
        "category": "New Drug Development"
      },
      {
        "id": 5,
        "name": "ImmuneBridge",
        "description": "免疫幹細胞擴增技術x精準基因工程",
        "presenter": "Nina Horowitz",
        "presenter_title": "CSO",
        "photo": "https://expo.taiwan-healthcare.org//data/tmp/20241028/20241028r782rx.png",
        "category": "Immunotherapy・Gene Therapy"
      },
      {
        "id": 6,
        "name": "Cirsium Biosciences",
        "description": "獨創植物細胞生產病毒載體技術",
        "presenter": "Jake Connors",
        "presenter_title": "CTO/ Co-Founder",
        "photo": "https://expo.taiwan-healthcare.org//data/tmp/20241028/20241028e18olj.jpg",
        "category": "Immunotherapy・Gene Therapy"
      },
      {
        "id": 7,
        "name": "Rejuvenate Bio",
        "description": "哈佛團隊研發老化疾病基因療法",
        "presenter": "Daniel Oliver",
        "presenter_title": "CEO/ Co-Founder",
        "photo": "https://expo.taiwan-healthcare.org//data/tmp/20241028/20241028n6eq6u.jpg",
        "category": "Immunotherapy・Gene Therapy"
      },
      {
        "id": 8,
        "name": "Verlmmune",
        "description": "抗腫瘤免疫重定向創新療法",
        "presenter": "Joshua Wang",
        "presenter_title": "Founder/ CEO",
        "photo": "https://expo.taiwan-healthcare.org//data/tmp/20241028/20241028pcw926.jpg",
        "category": "Immunotherapy・Gene Therapy"
      },
      {
        "id": 9,
        "name": "Coastar Therapeutics",
        "description": "創新細胞膜包覆大分子藥物技術",
        "presenter": "Chongyang Luo",
        "presenter_title": "COO",
        "photo": "https://expo.taiwan-healthcare.org//data/tmp/20241028/20241028zr44k6.jpg",
        "category": "New Drug Development"
      },
      {
        "id": 10,
        "name": "Myrobalan Therapeutics",
        "description": "促進髓鞘再⽣新型⼝服神經修復藥物",
        "presenter": "Jing Wang",
        "presenter_title": "CEO/ Co-Founder",
        "photo": "https://expo.taiwan-healthcare.org//data/tmp/20241028/2024102820mamy.jpg",
        "category": "New Drug Development"
      },
      {
        "id": 11,
        "name": "Rapafusyn Pharmaceuticals",
        "description": "非降解分子膠FKBP藥物開發平台",
        "presenter": "Sean Hu",
        "presenter_title": "CEO",
        "photo": "https://expo.taiwan-healthcare.org//data/tmp/20241028/20241028hqd7yv.jpg",
        "category": "New Drug Development"
      },
      {
        "id": 12,
        "name": "Qritive",
        "description": "10倍速AI數位病理診斷",
        "presenter": "Bruno Occhipinti",
        "presenter_title": "CEO",
        "photo": "https://expo.taiwan-healthcare.org//data/tmp/20241028/2024102849bl9m.png",
        "category": "Medical Device・Smart Healthcare"
      },
      {
        "id": 13,
        "name": "HistoSonics",
        "description": "非侵入性聲波技術震碎肝臟腫瘤細胞",
        "presenter": "Josh King",
        "presenter_title": "Vice President",
        "photo": "https://expo.taiwan-healthcare.org//data/tmp/20241105/20241105jwz2nv.webp",
        "category": "Medical Device・Smart Healthcare"
      },
      {
        "id": 14,
        "name": "Niramai",
        "description": "以熱成像AI提高25%乳癌篩檢精準度",
        "presenter": "Vicky Nanda",
        "presenter_title": "COO",
        "photo": "https://expo.taiwan-healthcare.org//data/tmp/20241105/202411050pm3e7.jpg",
        "category": "Medical Device・Smart Healthcare"
      },
      {
        "id": 15,
        "name": "PRISM BioLab",
        "description": "以擬肽小分子調控蛋白質交互作用開發新藥",
        "presenter": "Dai Takehara",
        "presenter_title": "President & CEO",
        "photo": "https://expo.taiwan-healthcare.org//data/tmp/20241106/20241106hfai10.jpg",
        "category": "New Drug Development"
      },
      {
        "id": 16,
        "name": "SYNCELL",
        "description": "空間蛋白體學必備利器-可抓式顯微系統",
        "presenter": "Jung-Chi Liao",
        "presenter_title": "Founder / CEO",
        "photo": "https://expo.taiwan-healthcare.org//data/tmp/20241128/20241128joospa.png",
        "category": "New Drug Development"
      },
      {
        "id": 17,
        "name": "Pharmosa Biopharm",
        "description": "長效緩釋之肺部藥物遞送平台",
        "presenter": "Pei Kan",
        "presenter_title": "Co-Founder / CEO",
        "photo": "https://expo.taiwan-healthcare.org//data/tmp/20241128/20241128hh91l3.jpg",
        "category": "New Drug Development"
      },
      {
        "id": 18,
        "name": "Cytonus",
        "description": "以去核幹細胞為載體之精準藥物遞送平台",
        "presenter": "Remo Moomiaie-Qajar",
        "presenter_title": "CEO",
        "photo": "https://expo.taiwan-healthcare.org//data/tmp/20241202/20241202s7kcz8.jpg",
        "category": "New Drug Development"
      }
    ],
    "schedule": [
      {
        "id": 1,
        "day": "December 3",
        "events": [
          {
            "time": "10:00-10:10",
            "title": "Opening Remark",
            "type": "ceremony"
          },
          {
            "time": "10:10-10:50",
            "title": "AI-Driven Innovations and Opportunities in Drug Discovery",
            "type": "keynote",
            "speaker": "Ettikan Karuppiah, Director & Technologist, NVIDIA"
          },
          {
            "time": "10:50-11:30",
            "title": "Advancing Generative AI in Biomedicine: Next Steps and Opportunities",
            "type": "keynote",
            "speaker": "Keren Priyadarshini, Healthcare Lead, Microsoft Asia"
          },
          {
            "time": "11:30-13:00",
            "title": "Lunch Break",
            "type": "break"
          },
          {
            "time": "13:00-14:00",
            "title": "Investing in the Future of Healthcare: Trends and Opportunities in 2025",
            "type": "fireside_chat",
            "moderator": "Charles Lin, Principal, illumina Ventures",
            "panelists": [
              "Robert Mittendorff, General Partner & Head of Healthcare, B Capital",
              "Ian Chiang, Partner, Flare Capital Partners",
              "Nate Chang, Operating Partner, Playground Global",
              "Cheryl Cheng, Founder, Vive Collective"
            ]
          },
          {
            "time": "14:00-14:40",
            "title": "Pitch Session - Regenerative Medicine",
            "type": "pitch_session",
            "presenters": [
              "Tempo Therapeutics｜Westbrook Weaver, Founder & CEO",
              "EyeYon｜Nahum Ferera, Co-Founder & CEO",
              "EpiBone｜Nina Tandon, CEO"
            ]
          },
          {
            "time": "14:40-15:10",
            "title": "Coffee Break",
            "type": "break"
          },
          {
            "time": "15:10-16:00",
            "title": "Pitch Session - Immunotherapy・Gene Therapy",
            "type": "pitch_session",
            "presenters": [
              "ImmuneBridge｜Nina Horowitz, CSO",
              "Cirsium Biosciences｜Jake Connors, Co-Founder & CTO",
              "Rejuvenate Bio｜Daniel Oliver, Co-Founder & CEO",
              "Verlmmune｜Joshua Wang, Founder & CEO"
            ]
          },
          {
            "time": "16:00-16:40",
            "title": "Pitch Session - New Drug Development (I)",
            "type": "pitch_session",
            "presenters": [
              "SYNCELL｜Jung-Chi Liao, Founder & CEO",
              "Pharmosa Biopharm｜Pei Kan, Co-Founder & CEO",
              "Coastar Therapeutics｜Chongyang Luo, COO"
            ]
          },
          {
            "time": "16:40-17:30",
            "title": "Post-Event Networking",
            "type": "networking"
          }
        ]
      }
    ],
    "pastEvents": [
      {
        "id": 1,
        "year": 2024,
        "image": "https://expo.taiwan-healthcare.org/zh/medtex/2024",
        "link": "https://expo.taiwan-healthcare.org/zh/medtex/2024"
      },
      {
        "id": 2,
        "year": 2023,
        "image": "https://expo.taiwan-healthcare.org/zh/news/0s1o793l55fahub5",
        "link": "https://expo.taiwan-healthcare.org/zh/news/0s1o793l55fahub5"
      }
    ],
    "registrationPage": {
      "packages": [
        {
          "id": "conference_only",
          "name": "Startup Forum",
          "price": "$79", 
          "description": [
            "Access to all sessions",
            "Networking opportunities",
            "Lunch included"
          ]
        },
        {
          "id": "conference_and_party",
          "name": "Startup Forum + Networking Party",
          "price": "$199",
          "description": [
            "Access to all sessions",
            "Networking opportunities",
            "Lunch included",
            "Live music",
            "Drinks and snacks",
            "Networking"
          ]
        }
      ],
      "notes": {
        "deadline": "Only a limited number of spots are available. Register early to secure your place.",
        "terms": [
          "Cancellations and refunds are not accepted for this event.",
          "In the event of force majeure (e.g., natural disasters), the organizer reserves the right to postpone or cancel the event.",
          "By registering, you agree to allow the organizer to collect and use your personal information for event-related communication and follow-up notifications."
        ]
      }
    },
    "companyTypes": [
      { "value": "startup", "label": "Startup" },
      { "value": "sme", "label": "Small/Medium Enterprise" },
      { "value": "listed", "label": "Listed Company" },
      { "value": "investor", "label": "Investment Institution / VC" },
      { "value": "academic", "label": "Academic/Research Institution" },
      { "value": "government", "label": "Government / Association" },
      { "value": "other", "label": "Other" }
    ],
    "startup_teams": [
      {
        "id": 1,
        "name": "Tempo Therapeutics",
        "logo": "https://expo.taiwan-healthcare.org//data/tmp/20241028/202410285ts46s.jpg",
        "description": "微孔凝膠組織再生全新材料",
        "country": "United States",
        "lead_investors": "Khosla Ventures, MPM Capital",
        "status": "published",
        "created_at": "2023-10-15T08:30:00Z",
        "updated_at": "2024-05-20T14:15:00Z"
      },
      {
        "id": 2,
        "name": "EyeYon",
        "logo": "https://expo.taiwan-healthcare.org//data/tmp/20241028/20241028xqekka.jpeg",
        "description": "人工眼角膜移植新科技！",
        "country": "Israel",
        "lead_investors": "TriVentures, BRM Group",
        "status": "published",
        "created_at": "2023-11-05T10:45:00Z",
        "updated_at": "2024-06-10T09:20:00Z"
      },
      {
        "id": 3,
        "name": "EpiBone",
        "logo": "https://expo.taiwan-healthcare.org//data/tmp/20241028/20241028y81103.jpeg",
        "description": "創新脂肪幹細胞製程生成骨移植物",
        "country": "United States",
        "lead_investors": "Pier 70 Ventures, SoftBank Vision Fund",
        "status": "published",
        "created_at": "2023-09-28T15:20:00Z",
        "updated_at": "2024-05-15T11:30:00Z"
      },
      {
        "id": 4,
        "name": "Arbor Biotechnologies",
        "logo": "https://expo.taiwan-healthcare.org//data/tmp/20241028/202410280h2pfw.jpg",
        "description": "張鋒團隊！全球最新高效CRISPR平台",
        "country": "United States",
        "lead_investors": "Arch Venture Partners, Forestry LLC",
        "status": "published",
        "created_at": "2023-12-10T09:15:00Z",
        "updated_at": "2024-06-05T16:40:00Z"
      }
    ],
    "startup_representatives": [
      {
        "id": 1,
        "team_id": 1,
        "name": "Westbrook Weaver",
        "photo": "https://expo.taiwan-healthcare.org//data/tmp/20241028/202410285ts46s.jpg",
        "title": "Founder/CEO"
      },
      {
        "id": 2,
        "team_id": 2,
        "name": "Nahum Ferera",
        "photo": "https://expo.taiwan-healthcare.org//data/tmp/20241028/20241028xqekka.jpeg",
        "title": "CEO/Co-Founder"
      },
      {
        "id": 3,
        "team_id": 3,
        "name": "Nina Tandon",
        "photo": "https://expo.taiwan-healthcare.org//data/tmp/20241028/20241028y81103.jpeg",
        "title": "CEO"
      },
      {
        "id": 4,
        "team_id": 4,
        "name": "David Cheng",
        "photo": "https://expo.taiwan-healthcare.org//data/tmp/20241028/202410280h2pfw.jpg",
        "title": "CTO"
      }
    ],
    "startup_investments": [
      {
        "id": 1,
        "team_id": 1,
        "year_founded": 2017,
        "total_funding": "$45M",
        "annual_revenue": "$5M",
        "is_pre_revenue": false,
        "funding_round": "Series B",
        "amount_raised": "$30M",
        "valuation": "$120M",
        "on_market": "Private"
      },
      {
        "id": 2,
        "team_id": 2,
        "year_founded": 2015,
        "total_funding": "$36M",
        "annual_revenue": "$2.5M",
        "is_pre_revenue": false,
        "funding_round": "Series B",
        "amount_raised": "$20M",
        "valuation": "$90M",
        "on_market": "Private"
      },
      {
        "id": 3,
        "team_id": 3,
        "year_founded": 2012,
        "total_funding": "$56M",
        "annual_revenue": "$8M",
        "is_pre_revenue": false,
        "funding_round": "Series C",
        "amount_raised": "$35M",
        "valuation": "$180M",
        "on_market": "Private"
      },
      {
        "id": 4,
        "team_id": 4,
        "year_founded": 2018,
        "total_funding": "$125M",
        "annual_revenue": "$0",
        "is_pre_revenue": true,
        "funding_round": "Series B",
        "amount_raised": "$75M",
        "valuation": "$300M",
        "on_market": "Private"
      }
    ],
    "startup_details": [
      {
        "id": 1,
        "team_id": 1,
        "investment_highlights": "市場規模估達100億美元，獨家專利技術能夠顯著加速組織再生過程",
        "core_technology": "微孔凝膠技術平台能夠模擬細胞外基質結構，優化細胞生長環境",
        "target_market": "外科手術修復市場，特別是骨科與傷口癒合",
        "milestones": "預計2025年開始FDA臨床II期試驗，2026年進入歐洲市場"
      },
      {
        "id": 2,
        "team_id": 2,
        "investment_highlights": "全球約有5000萬角膜疾病患者，本產品可大幅降低眼角膜移植困難度",
        "core_technology": "合成角膜材料能夠與人體組織良好結合，降低排斥反應",
        "target_market": "眼科手術市場，特別是角膜移植領域",
        "milestones": "已通過歐盟CE認證，正在進行美國FDA審批過程"
      },
      {
        "id": 3,
        "team_id": 3,
        "investment_highlights": "骨移植市場每年成長10%以上，技術能夠避免傳統骨移植併發症",
        "core_technology": "使用病患自體脂肪幹細胞培養客製化骨骼組織，完全避免排斥問題",
        "target_market": "骨科手術市場，特別是顱顏骨缺損修復領域",
        "milestones": "已完成FDA I/II期臨床試驗，預計2025年上市"
      },
      {
        "id": 4,
        "team_id": 4,
        "investment_highlights": "基因編輯市場規模超過100億美元，技術比現有CRISPR系統精準度高50%",
        "core_technology": "AI驅動的CRISPR工具發現平台，能夠識別並優化全新的基因編輯酶",
        "target_market": "基因治療、生物技術研發工具市場",
        "milestones": "已與三家全球前20大製藥公司簽訂合作研發協議"
      }
    ],
    "startup_products": [
      {
        "id": 1,
        "team_id": 1,
        "name": "TempoPatch",
        "category": "device",
        "stage": "臨床前研究完成，準備進入人體試驗",
        "certificate_country": "美國"
      },
      {
        "id": 2,
        "team_id": 1,
        "name": "TempoMatrix",
        "category": "device",
        "stage": "動物試驗階段",
        "certificate_country": "美國"
      },
      {
        "id": 3,
        "team_id": 2,
        "name": "EndoArt",
        "category": "device",
        "stage": "已通過CE認證，進入歐洲市場",
        "certificate_country": "歐盟"
      },
      {
        "id": 4,
        "team_id": 3,
        "name": "EB-1 Bone Graft",
        "category": "device",
        "stage": "臨床二期試驗",
        "certificate_country": "美國"
      },
      {
        "id": 5,
        "team_id": 4,
        "name": "CRISPR Type V Platform",
        "category": "service",
        "stage": "研發階段，已開放給合作夥伴使用",
        "certificate_country": "N/A"
      },
      {
        "id": 6,
        "team_id": 4,
        "name": "Gene-Edit Pro Kit",
        "category": "device",
        "stage": "已商業化，供研究使用",
        "certificate_country": "美國"
      }
    ]
  }
  